Cellmid Limited (ASX: CDY) advises that it has received TGA registration for its Évolis™ hair growth product range as “listed medicine”.
|
Cellmid Limited (ASX: CDY) advises that it has signed an agreement with La Jolla Cove Investors to terminate the Funding Agreement dated September 2010.
|
Cellmid Limited (ASX: CDY) completed its diagnostic study in Kumamoto, Japan, measuring the blood midkine levels of 233 healthy volunteers.
|
Cellmid Limited (ASX:CDY) wishes to provide information in relation to the ordinary shares issued
in connection with the Company's $0.17 per share rights offer that closed recently.
|